| 25th Apr 2016 7:00 am |
RNS |
Replay for Analyst & Investor Conference Call |
| 22nd Apr 2016 7:00 am |
RNS |
Grant of Options |
| 21st Apr 2016 7:00 am |
RNS |
Annual Report and Accounts 2015 |
| 20th Apr 2016 7:00 am |
RNS |
Final Results |
| 18th Apr 2016 7:00 am |
RNS |
Results Conference Call Details |
| 14th Apr 2016 7:00 am |
RNS |
Senior Appointments |
| 23rd Mar 2016 7:00 am |
RNS |
Motif Bio to present at BIO-Europe Spring |
| 14th Mar 2016 7:00 am |
RNS |
Appointment of strategic adviser |
| 2nd Mar 2016 7:00 am |
RNS |
First patient dosed in iclaprim Phase 3 trials |
| 23rd Feb 2016 5:39 pm |
RNS |
Holding(s) in Company |
| 22nd Feb 2016 7:00 am |
RNS |
Webcast on Combating antibiotic resistance |
| 25th Jan 2016 7:00 am |
RNS |
Appointments of U.S. finance adviser and auditor |
| 22nd Dec 2015 7:00 am |
RNS |
Exercise of Warrants |
| 15th Dec 2015 7:00 am |
RNS |
Iclaprim Clinical Trial Supplies Manufactured |
| 7th Dec 2015 7:00 am |
RNS |
Motif selected to present at Biotech Showcase |
| 24th Nov 2015 7:00 am |
RNS |
Receipt of FDA Concurrence |
| 11th Nov 2015 7:00 am |
RNS |
European Agreement for Iclaprim Development |
| 27th Oct 2015 7:00 am |
RNS |
Selected to Present at BIO-Europe 2015 |
| 21st Oct 2015 7:00 am |
RNS |
Exercise of Options |
| 16th Oct 2015 7:00 am |
RNS |
Leading CRO to Conduct Iclaprim Phase III Trials |
| 13th Oct 2015 7:00 am |
RNS |
Results of Two Posters on Iclaprim at ID Week 2015 |
| 12th Oct 2015 3:59 pm |
RNS |
Exercise of Options |
| 5th Oct 2015 4:41 pm |
RNS |
Directors Dealings |
| 29th Sep 2015 7:01 am |
RNS |
Presentation of Two Posters on Iclaprim |
| 23rd Sep 2015 3:04 pm |
RNS |
Issue of Shares for Exercised Warrants |
| 3rd Sep 2015 7:00 am |
RNS |
FDA Grants Fast Track Designation for Iclaprim |
| 2nd Sep 2015 7:00 am |
RNS |
Appointment of IR Adviser |
| 2nd Sep 2015 7:00 am |
RNS |
Participation at Upcoming Investor Events |
| 27th Aug 2015 7:01 am |
RNS |
Interims Results for the 6 months to 30 June 2015 |
| 24th Aug 2015 7:00 am |
RNS |
Potent Efficacy of Iclaprim Confirmed |
| 22nd Jul 2015 4:32 pm |
RNS |
FDA QIDP Designation |
| 22nd Jul 2015 7:00 am |
RNS |
Final condition of £22m placing satisfied |
| 20th Jul 2015 7:00 am |
RNS |
Exercise of Options |
| 17th Jul 2015 7:00 am |
RNS |
FDA QIDP Designation for Iclaprim for HABP |
| 15th Jul 2015 7:00 am |
RNS |
New Addition to Scientific Advisory Board |
| 10th Jul 2015 3:29 pm |
RNS |
Exercise of Options |
| 10th Jul 2015 1:37 pm |
RNS |
Result of General Meeting |
| 23rd Jun 2015 8:47 am |
RNS |
Partner Company raises £22 million |
| 23rd Jun 2015 7:00 am |
RNS |
Placing to raise £22 million and Change of Adviser |
| 9th Jun 2015 7:00 am |
RNS |
Audited Non-Statutory Financial Statements |
